What does Beihai Gofar Chuanshan Biological Co., Ltd. do?

Beihai Gofar Chuanshan Biological Co., Ltd. (600538.SS) operates in the Medical - Pharmaceuticals industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is 600538.SS's market cap?

Beihai Gofar Chuanshan Biological Co., Ltd. (600538.SS) has a market capitalization of approximately $2.73 billion, as of August 27, 2026, based on the most recent share price and shares outstanding.

Does 600538.SS pay a dividend?

Yes — Beihai Gofar Chuanshan Biological Co., Ltd. (600538.SS) has a dividend payment history. The most recent payment, frequency, and full history are on the Dividend tab.

Is 600538.SS profitable?

Beihai Gofar Chuanshan Biological Co., Ltd. (600538.SS) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

600538.SS

Beihai Gofar Chuanshan Biological Co., Ltd.

SHH·Medical, Pharmaceuticals · Healthcare

¥5.21¥0.02−0.38%

Market cap¥2.73B·Market closed·Aug 27 3:04 AM UTC

Price Chart

¥5.21−¥0.02 (−0.38%)today

−36.62%CAGR −8.72%

Select date range

FromTo

Jan 14, 2003Aug 27, 2021 → Aug 27, 2026· 5.0 yrsAug 27, 2026

Key Metrics

600538.SS does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateMay 16

Last Report DateApr 28

Reported vs Estimate¥0.01

Earnings Surprise—

FinancialsFinancials Tab

Revenue¥332.27M

Net Income−¥98.32M

Net Margin−29.6%

Operating Cash Flow−¥16.13M

Capital Expenditures¥5.60M

Free Cash Flow−¥21.73M

Return on Equity−14.5%

Return on Invested Capital−0.4%

Net Cash¥62.62M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 600538.SS and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 600538.SS's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 600538.SS and 80,000+ other tickers.

About Beihai Gofar Chuanshan Biological Co., Ltd.

Beihai Gofar Chuanshan Biological Co., Ltd., together with its subsidiaries, engages in the distribution of pharmaceutical products in China. It operates through Pharmaceutical Distribution [Industry]; Pharmaceutical Manufacturing; DNA Testing Equipment, Consumables and Testing Services; and Others segments. The company wholesales and retails various medicines and medical devices through directly operated and franchised chain drugstores. It also provides pearl eye drops, pearl powder, and pearl layer powder under the Haibao brand; weichangning granules under the Guofa brand; ethanol…

CEO: Li Bin Pan
Sector: Healthcare
Industry: Medical - Pharmaceuticals
Exchange: SHH
Employees: 438
Website: www.gofar.com.cn

Peers

Peers Tab

300575.SZ

Jiangsu Flag Chemical Industry Co., Ltd.

Cap

¥2.9B

600470.SS

Anhui Liuguo Chemical Co., Ltd.

Cap

¥3.2B

600257.SS

Dahu Health Industry Co., Ltd.

Cap

¥2.7B

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 600538.SS

What does Beihai Gofar Chuanshan Biological Co., Ltd. do?: Beihai Gofar Chuanshan Biological Co., Ltd. (600538.SS) operates in the Medical - Pharmaceuticals industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 600538.SS's market cap?: Beihai Gofar Chuanshan Biological Co., Ltd. (600538.SS) has a market capitalization of approximately $2.73 billion, as of August 27, 2026, based on the most recent share price and shares outstanding.
Does 600538.SS pay a dividend?: Yes — Beihai Gofar Chuanshan Biological Co., Ltd. (600538.SS) has a dividend payment history. The most recent payment, frequency, and full history are on the Dividend tab.
Is 600538.SS profitable?: Beihai Gofar Chuanshan Biological Co., Ltd. (600538.SS) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.